25-hydroxycholesterol has been researched along with 2019 Novel Coronavirus Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 6 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Jiang, S; Jiao, F; Lan, Q; Lu, L; Wang, C; Wang, L; Xia, S; Zhang, Y; Zhou, J | 1 |
| Lin, J; Mao, S; Meng, Y; Pan, C; Ren, J; Xu, N; Xu, Y | 1 |
| Leist, SR; Mock, JR | 1 |
| Keyvani, H; Mousavizadeh, L; Nejati, F; Razizadeh, MH; Roozbehani, M; Soleymani, S | 1 |
| Chen, Q; Cheng, G; Deng, YQ; Gold, S; He, J; Li, J; Li, L; Li, X; Li, XF; Qin, CF; Yang, H; Zhang, C; Zhao, H; Zhou, C; Zu, S | 1 |
| Bose, S; Case, JB; Diamond, MS; Ding, S; Diwan, A; Fremont, DH; Gomez Castro, MF; Griffiths, WJ; Guo, H; Hou, G; Kirchhausen, T; Kreutzberger, AJB; Liu, Z; Ma, X; Mani, K; Rothlauf, PW; Shen, S; Son, J; Vahey, MD; Wang, X; Wang, Y; Whelan, SPJ; Yutuc, E; Zang, R; Zeng, Q; Zhang, H; Zhao, H | 1 |
1 review(s) available for 25-hydroxycholesterol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Studies in the antiviral molecular mechanisms of 25-hydroxycholesterol: Disturbing cholesterol homeostasis and post-translational modification of proteins.
Topics: Antiviral Agents; Cholesterol; COVID-19; Homeostasis; Humans; Hydroxycholesterols; Oxysterols; Protein Processing, Post-Translational; Viral Proteins | 2022 |
5 other study(ies) available for 25-hydroxycholesterol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses.
Topics: Amino Acid Sequence; Animals; Antiviral Agents; Body Weight; Coronavirus 229E, Human; Coronavirus Infections; Coronavirus OC43, Human; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Drug Synergism; Humans; Hydroxycholesterols; Lipopeptides; Mice; Mice, Inbred BALB C; Polyethylene Glycols; SARS-CoV-2; Survival Rate; Virus Internalization | 2021 |
The Importance of "Negative" Results: Lipid Lessons in Coronavirus Biology.
Topics: Animals; Biology; COVID-19; Hydroxycholesterols; Mice; SARS-CoV-2 | 2023 |
Expression Pattern of Cholesterol 25-Hydroxylase and Serum Level of 25-Hydroxycholesterol and Relevant Inflammatory Cytokines in Patients with Varying Disease Severity of COVID-19.
Topics: Animals; Antiviral Agents; COVID-19; Cytokines; Humans; Interferon-alpha; Iran; Leukocytes, Mononuclear; Mice; Patient Acuity; SARS-CoV-2; Virus Replication | 2023 |
25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor.
Topics: Aged; Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Disease Models, Animal; Fatal Outcome; Female; Humans; Hydroxycholesterols; Mice; Mice, Inbred BALB C; Mice, Transgenic; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Vero Cells; Virus Replication | 2020 |
Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion.
Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Endosomes; Humans; Hydroxycholesterols; Interferons; Membrane Fusion; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Virus Internalization; Virus Replication | 2020 |